Search Result

Results for "

ArlS

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Antibiotic (3) Bacterial (3) Cholecystokinin Receptor (1) NO Synthase (1) NTPDase (3) Phosphatase (1) Small Interfering RNA (siRNA) (24)
By Research Areas:	Cancer (1) Cardiovascular Disease (3) Endocrinology (1) Infection (3) Inflammation/Immunology (6)
Oligonucleotides:	Pre-designed siRNA Sets (24) siRNAs (24)

Inhibitors & Agonists

Peptides

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-107720

ARL 17477	NO Synthase	Cancer
ARL-17477 is a dual inhibitor of NOS1and the autophagy-lysosomal system with anticancer activity and can inhibit tumor growth in KRAS-mutated cancers .

HY-RS00977

ARL1 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ARL1 Human Pre-designed siRNA Set A contains three designed siRNAs for ARL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL1 Human Pre-designed siRNA Set A ARL1 Human Pre-designed siRNA Set A

HY-RS00978

ARL10 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ARL10 Human Pre-designed siRNA Set A contains three designed siRNAs for ARL10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL10 Human Pre-designed siRNA Set A ARL10 Human Pre-designed siRNA Set A

HY-RS00979

ARL11 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ARL11 Human Pre-designed siRNA Set A contains three designed siRNAs for ARL11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL11 Human Pre-designed siRNA Set A ARL11 Human Pre-designed siRNA Set A

HY-RS00981

ARL14 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ARL14 Human Pre-designed siRNA Set A contains three designed siRNAs for ARL14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL14 Human Pre-designed siRNA Set A ARL14 Human Pre-designed siRNA Set A

HY-RS00983

ARL15 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ARL15 Human Pre-designed siRNA Set A contains three designed siRNAs for ARL15 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL15 Human Pre-designed siRNA Set A ARL15 Human Pre-designed siRNA Set A

HY-RS00984

ARL16 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ARL16 Human Pre-designed siRNA Set A contains three designed siRNAs for ARL16 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL16 Human Pre-designed siRNA Set A ARL16 Human Pre-designed siRNA Set A

HY-RS00985

ARL2 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ARL2 Human Pre-designed siRNA Set A contains three designed siRNAs for ARL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL2 Human Pre-designed siRNA Set A ARL2 Human Pre-designed siRNA Set A

HY-RS00987

ARL3 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ARL3 Human Pre-designed siRNA Set A contains three designed siRNAs for ARL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL3 Human Pre-designed siRNA Set A ARL3 Human Pre-designed siRNA Set A

HY-RS00988

ARL4A Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ARL4A Human Pre-designed siRNA Set A contains three designed siRNAs for ARL4A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL4A Human Pre-designed siRNA Set A ARL4A Human Pre-designed siRNA Set A

HY-RS00991

ARL5A Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ARL5A Human Pre-designed siRNA Set A contains three designed siRNAs for ARL5A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL5A Human Pre-designed siRNA Set A ARL5A Human Pre-designed siRNA Set A

HY-RS00993

ARL6 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ARL6 Human Pre-designed siRNA Set A contains three designed siRNAs for ARL6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL6 Human Pre-designed siRNA Set A ARL6 Human Pre-designed siRNA Set A

HY-RS00998

ARL8A Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ARL8A Human Pre-designed siRNA Set A contains three designed siRNAs for ARL8A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL8A Human Pre-designed siRNA Set A ARL8A Human Pre-designed siRNA Set A

HY-RS01000

ARL9 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ARL9 Human Pre-designed siRNA Set A contains three designed siRNAs for ARL9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL9 Human Pre-designed siRNA Set A ARL9 Human Pre-designed siRNA Set A

HY-103265A

ARL67156 FPL 67156	Phosphatase	Others
ARL67156 is an inhibitor of ecto-ATPase. ARL 67156 is a weak competitive inhibitor of NTPDase1 (CD39), NTPDase3 and NPP1, with K_is of 11, 18 and 12 μM, respectively .

HY-RS00980

ARL13B Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ARL13B Human Pre-designed siRNA Set A contains three designed siRNAs for ARL13B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL13B Human Pre-designed siRNA Set A ARL13B Human Pre-designed siRNA Set A

HY-RS00982

ARL14EP Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ARL14EP Human Pre-designed siRNA Set A contains three designed siRNAs for ARL14EP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL14EP Human Pre-designed siRNA Set A ARL14EP Human Pre-designed siRNA Set A

HY-RS00986

ARL2BP Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ARL2BP Human Pre-designed siRNA Set A contains three designed siRNAs for ARL2BP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL2BP Human Pre-designed siRNA Set A ARL2BP Human Pre-designed siRNA Set A

HY-RS00989

ARL4C Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ARL4C Human Pre-designed siRNA Set A contains three designed siRNAs for ARL4C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL4C Human Pre-designed siRNA Set A ARL4C Human Pre-designed siRNA Set A

HY-RS00990

ARL4D Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ARL4D Human Pre-designed siRNA Set A contains three designed siRNAs for ARL4D gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL4D Human Pre-designed siRNA Set A ARL4D Human Pre-designed siRNA Set A

HY-RS00992

ARL5B Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ARL5B Human Pre-designed siRNA Set A contains three designed siRNAs for ARL5B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL5B Human Pre-designed siRNA Set A ARL5B Human Pre-designed siRNA Set A

HY-RS00999

ARL8B Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ARL8B Human Pre-designed siRNA Set A contains three designed siRNAs for ARL8B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL8B Human Pre-designed siRNA Set A ARL8B Human Pre-designed siRNA Set A

HY-B1831

Oritavancin LY 333328; Orbactiv	Antibiotic Bacterial	Infection Inflammation/Immunology
Oritavancin (LY 333328), a semisynthetic derivative of Vancomycin (HY-B0671), is an orally active glycopeptide antibiotic with bactericidal activity against gram-positive organisms. Oritavancin shows antibacterial effect against B. anthracis, such as Ames strain with a MIC value of 0.015 g/mL. Oritavancin inhibits cell wall synthesis and disrupts the membrane potential. Oritavancin inhibits *ArlS* kinase activity thereby interfering the signal transduction. Oritavancin enters cells by adsorptive endocytosis, which drives it to lysosomes, where it exerts antibiotic activity .

HY-RS00994

ARL6IP1 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ARL6IP1 Human Pre-designed siRNA Set A contains three designed siRNAs for ARL6IP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL6IP1 Human Pre-designed siRNA Set A ARL6IP1 Human Pre-designed siRNA Set A

HY-RS00995

ARL6IP4 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ARL6IP4 Human Pre-designed siRNA Set A contains three designed siRNAs for ARL6IP4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL6IP4 Human Pre-designed siRNA Set A ARL6IP4 Human Pre-designed siRNA Set A

HY-RS00996

ARL6IP5 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ARL6IP5 Human Pre-designed siRNA Set A contains three designed siRNAs for ARL6IP5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL6IP5 Human Pre-designed siRNA Set A ARL6IP5 Human Pre-designed siRNA Set A

HY-RS00997

ARL6IP6 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ARL6IP6 Human Pre-designed siRNA Set A contains three designed siRNAs for ARL6IP6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL6IP6 Human Pre-designed siRNA Set A ARL6IP6 Human Pre-designed siRNA Set A

HY-103265

ARL67156 trisodium 2 Publications Verification FPL 67156 trisodium	NTPDase	Cardiovascular Disease Inflammation/Immunology
ARL67156 (FPL 67156) trisodium is a selective small molecular inhibitor, targeting to ecto-ATPase, CD39, and CD73. ARL67156 trisodium is also a competitive inhibitor of NTPDase1 (CD39), NTPDase3 and NPP1, with K_is of 11, 18 and 12?μM, respectively. ARL67156 trisodium can be used in the research of calcific aortic valve disease, asthma .

HY-B1831A

Oritavancin diphosphate 1 Publications Verification LY333328 diphosphate	Bacterial Antibiotic	Infection Inflammation/Immunology
Oritavancin diphosphate (LY333328 diphosphate), a semisynthetic derivative of Vancomycin (HY-B0671), is an orally active glycopeptide antibiotic with bactericidal activity against gram-positive organisms. Oritavancin diphosphate shows antibacterial effect against B. anthracis, such as Ames strain with a MIC value of 0.015 g/mL. Oritavancin diphosphate inhibits cell wall synthesis and disrupts the membrane potential. Oritavancin diphosphate inhibits *ArlS* kinase activity thereby interfering the signal transduction. Oritavancin diphosphate enters cells by adsorptive endocytosis, which drives it to lysosomes, where it exerts antibiotic activity .

HY-103265B

ARL67156 trisodium hydrate 2 Publications Verification FPL 67156 trisodium hydrate	NTPDase	Cardiovascular Disease Inflammation/Immunology
ARL67156 (FPL 67156) trisodium hydrate is a selective small is a selective samll molecular inhibitor, targeting to ecto-ATPase, CD39, and CD73. ARL67156 trisodium hydrate is also a competitive inhibitor of NTPDase1 (CD39), NTPDase3 and NPP1, with K_is of 11, 18 and 12?μM, respectively. ARL67156 trisodium hydrate can be used in the research of disease like calcific aortic valve disease, asthma .

HY-103265D

ARL67156 triethylamine 2 Publications Verification FPL 67156 triethylamine	NTPDase	Cardiovascular Disease Inflammation/Immunology
ARL67156 (FPL 67156) triethylamine is a selective small is a selective samll molecular inhibitor, targeting to ecto-ATPase, CD39, and CD73. ARL67156 triethylamine is also a competitive inhibitor of NTPDase1 (CD39), NTPDase3 and NPP1, with K_is of 11, 18 and 12?μM, respectively. ARL67156 triethylamine can be used in the research of disease like calcific aortic valve disease, asthma .

HY-B1831AR

Oritavancin diphosphate (Standard)	Bacterial Antibiotic	Infection Inflammation/Immunology
Oritavancin (diphosphate) (Standard) is the analytical standard of Oritavancin (diphosphate). Oritavancin diphosphate (Standard), a semisynthetic derivative of Vancomycin (HY-B0671), is an orally active glycopeptide antibiotic with bactericidal activity against gram-positive organisms. Oritavancin diphosphate (Standard) shows antibacterial effect against B. anthracis, such as Ames strain with a MIC value of 0.015 g/mL. Oritavancin diphosphate (Standard) inhibits cell wall synthesis and disrupts the membrane potential. Oritavancin diphosphate (Standard) inhibits *ArlS* kinase activity thereby interfering the signal transduction. Oritavancin diphosphate (Standard) enters cells by adsorptive endocytosis, which drives it to lysosomes, where it exerts antibiotic activity .

HY-P1710

ARL 15849XX	Cholecystokinin Receptor	Endocrinology
ARL 15849XX is a cholecystokinin-8 (CCK-8) analog .

ARL 15849XX	Cholecystokinin Receptor	Endocrinology
ARL 15849XX is a cholecystokinin-8 (CCK-8) analog .

ARL1 Human Pre-designed siRNA Set A		siRNAs Pre-designed siRNA Sets
ARL1 Human Pre-designed siRNA Set A contains three designed siRNAs for ARL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL10 Human Pre-designed siRNA Set A		siRNAs Pre-designed siRNA Sets
ARL10 Human Pre-designed siRNA Set A contains three designed siRNAs for ARL10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL11 Human Pre-designed siRNA Set A		siRNAs Pre-designed siRNA Sets
ARL11 Human Pre-designed siRNA Set A contains three designed siRNAs for ARL11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL14 Human Pre-designed siRNA Set A		siRNAs Pre-designed siRNA Sets
ARL14 Human Pre-designed siRNA Set A contains three designed siRNAs for ARL14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL15 Human Pre-designed siRNA Set A		siRNAs Pre-designed siRNA Sets
ARL15 Human Pre-designed siRNA Set A contains three designed siRNAs for ARL15 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL16 Human Pre-designed siRNA Set A		siRNAs Pre-designed siRNA Sets
ARL16 Human Pre-designed siRNA Set A contains three designed siRNAs for ARL16 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL2 Human Pre-designed siRNA Set A		siRNAs Pre-designed siRNA Sets
ARL2 Human Pre-designed siRNA Set A contains three designed siRNAs for ARL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL3 Human Pre-designed siRNA Set A		siRNAs Pre-designed siRNA Sets
ARL3 Human Pre-designed siRNA Set A contains three designed siRNAs for ARL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL4A Human Pre-designed siRNA Set A		siRNAs Pre-designed siRNA Sets
ARL4A Human Pre-designed siRNA Set A contains three designed siRNAs for ARL4A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ARL5A Human Pre-designed siRNA Set A		siRNAs Pre-designed siRNA Sets
ARL5A Human Pre-designed siRNA Set A contains three designed siRNAs for ARL5A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: